BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 15025319)

  • 1. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
    Singh A; Ramesh V; Ramam M
    Indian J Dermatol Venereol Leprol; 2015; 81(1):29-34. PubMed ID: 25566893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
    Ramesh V
    Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
    [No Abstract]   [Full Text] [Related]  

  • 7. Leishmaniasis of the nose caused by different species of Leishmania in the Sudan. Distinguishing features of the different clinical forms.
    el-Hassan AM; Yagi HI; Zijlstra EE; el-Kadarow AI
    Trop Geogr Med; 1994; 46(1):33-6. PubMed ID: 8165735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
    el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
    Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral kala-azar associated with post-kala-azar dermal leishmaniasis.
    Singh NK; Agrawal SK; Jha TK
    J Assoc Physicians India; 1989 Feb; 37(2):191. PubMed ID: 2808294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypopigmented post-kala-azar dermal leishmaniasis.
    Ramesh V; Ramam M; Singh R; Salotra P
    Int J Dermatol; 2008 Apr; 47(4):414-6. PubMed ID: 18377613
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
    Dhar S; Malakar S
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
    [No Abstract]   [Full Text] [Related]  

  • 13. LD body-negative bone marrow cases of kala-azar in Dharan, Nepal.
    Karki P; Parija SC; Koirala S
    J Commun Dis; 1999 Dec; 31(4):261-2. PubMed ID: 10937305
    [No Abstract]   [Full Text] [Related]  

  • 14. A chronic mutilating rhinopathy with a delayed diagnosis of mucocutaneous leishmaniasis.
    Karimbil SK; Kumari S; Celine MI; Joy A
    Int J Dermatol; 2010 Apr; 49(4):426-9. PubMed ID: 20465699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leishmaniasis (kala-azar, oriental sore, South American leishmaniasis)].
    Malamos B
    Wien Z Inn Med; 1967; 48(6):209-21. PubMed ID: 5630155
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphadenopathy in a child with Indian kala-azar in Dharan, Nepal.
    Singh K; Singh R; Parija SC
    Indian Pediatr; 1998 Nov; 35(11):1125-6. PubMed ID: 10216552
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-kala-azar dermal leishmaniasis simulating leprosy. (A case report).
    Lal S; Garg BR
    Lepr India; 1976 Jan; 48(1):81-3. PubMed ID: 191696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infection of mucosal leishmaniasis and extra pulmonary tuberculosis in a patient with inherent immune deficiency.
    Rathnayake D; Ranawake RR; Sirimanna G; Siriwardhane Y; Karunaweera N; De Silva R
    Int J Dermatol; 2010 May; 49(5):549-51. PubMed ID: 20534090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.